Source: Annual Congress 2011 - Adenosine and purigenic signalling in inflammatory lung disease
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
G. Folkerts (Utrecht, The Netherlands). Introductory talk: pharmacology of adenosine and purinergic signalling. Annual Congress 2011 - Adenosine and purigenic signalling in inflammatory lung disease

Member's Comments

No comment yet.

Related content which might interest you: Keynote lecture: Neuronal sensing in the airways: the role of TRP channels Source: Annual Congress 2010 - Airway sensation: the emerging role of the transient receptor potential (TRP) channels Year: 2010 Crosstalk between long acting b2-adrenergic receptor agonists and tiotropium: Crosstalk of b2-adrenergic and muscarinic receptors Source: Annual Congress 2010 - Regulation of airway pharmacology Year: 2010 LATE-BREAKING ABSTRACT: Inhibition of ATP-gated P2X3 channels by AF-219: An effective anti-tussive mechanism in chronic cough Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013 Anti-tussive effects of FAAH inhibition: The role of endocannabinoids and downstream signalling pathways in the inhibition of vagal sensory nerve activation Source: International Congress 2015 – Novel treatments for cough, asthma, COPD and bronchiectasis Year: 2015 Synergistic effects by combination of tiotropium with olodaterol result from cross talk between muscarinic and β2-adrenergic receptors via allosteric modulation Source: International Congress 2016 – Preclinical pharmacology: drug targets and mechanisms of action Year: 2016 Adenosine contracts human isolated bronchi via A1 receptor dependent mechanism Source: Annual Congress 2010 - Airway cells as targets for anti-inflammatory drugs Year: 2010 LATE-BREAKING ABSTRACT: The bitter tastants chloroquine and noscapine relax human bronchial smooth muscle by different effects on intracellular calcium signalling Source: International Congress 2014 – Latest insights in airway diseases Year: 2014 Beyond the dogma: novel β2-adrenoceptor signalling in the airways Source: Eur Respir J 2006; 27: 1286-1306 Year: 2006 Potential role of memantine in the prevention and treatment of COVID-19: its antagonism of nicotinic acetylcholine receptors and beyond Source: Eur Respir J, 56 (2) 2001610; 10.1183/13993003.01610-2020 Year: 2020 beta2-Agonists block tussive responses in guinea pigs via an atypical cAMP-dependent pathway Source: Eur Respir J 2010; 35: 647-654 Year: 2010 Decreased Wnt/β-catenin signaling in COPD: Possible involvement of Wnt antagonists Source: Annual Congress 2012 - New mechanisms in non-neoplastic and neoplastic lung diseases Year: 2012 Late Breaking Abstract - Role of Muscarinic M3 receptors in bronchial remodelling of severe asthma Source: International Congress 2017 – Late-breaking findings in asthma and COPD Year: 2017